Legal Representation
Attorney
Thomas M. Joseph
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 31, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 31, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 2, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 2, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 2, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 2, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 2, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 5, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 5, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Dec 5, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 16, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 25, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 25, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 25, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 4, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 13, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Mail order accredited retail specialty pharmacy services, namely dispensing limited distribution drugs via the mail; Accredited retail specialty pharmacy services, namely dispensing limited distribution drugs; Specialized retail pharmacy services for patients with particular medical conditions, namely dispensing limited distribution drugs
Additional Information
Design Mark
The mark consists of a stylized version of the term VRX with a gray V and a yellow RX.
Color Claim
The color(s) gray and yellow is/are claimed as a feature of the mark.
Pseudo Mark
V RX
Pseudo Mark
VANSCOY RX
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
RX